
<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>Whole genome sequencing identifies recurrent mutations in hepatocellular carcinoma</title>
    
    <meta name="author" content="bigcr">

    <!-- Enable responsive viewport -->
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="http://html5shim.googlecode.com/svn/trunk/html5.js"></script>
    <![endif]-->

    <!-- Le styles -->
    <link href="/assets/themes/twitter/bootstrap/css/bootstrap.2.2.2.min.css" rel="stylesheet">
    <link href="/assets/themes/twitter/css/style.css?body=1" rel="stylesheet" type="text/css" media="all">

    <!-- Le fav and touch icons -->
  <!-- Update these with your own images
    <link rel="shortcut icon" href="images/favicon.ico">
    <link rel="apple-touch-icon" href="images/apple-touch-icon.png">
    <link rel="apple-touch-icon" sizes="72x72" href="images/apple-touch-icon-72x72.png">
    <link rel="apple-touch-icon" sizes="114x114" href="images/apple-touch-icon-114x114.png">
  -->

    <!-- atom & rss feed -->
    <link href="/atom.xml" type="application/atom+xml" rel="alternate" title="Sitewide ATOM Feed">
    <link href="/rss.xml" type="application/rss+xml" rel="alternate" title="Sitewide RSS Feed">

  </head>

  <body>
    <div class="navbar">
      <div class="navbar-inner">
        <div class="container-narrow">
          <a class="brand" href="/">BGI Cancer Research</a>
          <ul class="nav">
	    <li><a href="/member.html">成员</a></li>
	    <li><a href="/paper.html">论文</a></li>
	    <li><a href="/news.html">新闻</a></li>
	    <li><a href="/en">English</a></li>
          </ul>
        </div>
      </div>
    </div>

    <div class="container-narrow">

      <div class="content">
        
<div class="page-header">
  <h1>Whole genome sequencing identifies recurrent mutations in hepatocellular carcinoma </h1>
</div>

<div class="row-fluid post-full">
  <div class="span12">
    <div class="date">
      <span>17 June 2013</span>
    </div>
    <div class="content">
      <p>doi: 10.1101/gr.154492.113</p>

<h5 id='zhengyan_kanhancheng_zhengxiao_liushuyu_lithomas_barberzhuolin_gonghuan_gaoke_haomelinda_d_willardjiangchun_xurobert_hauptscheinpaul_a_rejtojulio_fernandezguan_wangqinghui_zhangbo_wangronghua_chenjian_wangnikki_p_leewei_zhouzhao_linzhiyu_pengkang_yishengpei_chenlin_lixiaomei_fanjie_yangrui_yejia_jukai_wangheather_estrellashibing_dengping_weiming_qiuisabella_h_wulurjiangang_liumariam_e_ehsanichunsheng_zhangandrey_lobodawing_kin_sungamit_aggarwalronnie_t_poonsheung_tat_fanjames_hardwickjun_wangchristoph_reinhardhongyue_daiyingrui_lijohn_m_lukmao_mao'>Zhengyan Kan,Hancheng Zheng,Xiao Liu,Shuyu Li,Thomas Barber,Zhuolin Gong,Huan Gao,Ke Hao,Melinda D Willard,Jiangchun Xu,Robert Hauptschein,Paul A Rejto,Julio Fernandez,Guan Wang,Qinghui Zhang,Bo Wang,Ronghua Chen,Jian Wang,Nikki P Lee,Wei Zhou,Zhao Lin,Zhiyu Peng,Kang Yi,Shengpei Chen,Lin Li,Xiaomei Fan,Jie Yang,Rui Ye,Jia Ju,Kai Wang,Heather Estrella,Shibing Deng,Ping Wei,Ming Qiu,Isabella H Wulur,Jiangang Liu,Mariam E Ehsani,Chunsheng Zhang,Andrey Loboda,Wing Kin Sung,Amit Aggarwal,Ronnie T Poon,Sheung Tat Fan,James Hardwick,Jun Wang,Christoph Reinhard,Hongyue Dai,Yingrui Li,John M Luk,Mao Mao</h5>

<p>Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and has no effective treatment, yet the molecular basis of hepatocarcinogenesis remains largely unknown. Here we report findings from a whole genome sequencing (WGS) study of 88 matched HCC tumor/normal pairs, 81 of which are HBV positive, seeking to identify genetically altered genes and pathways implicated in HBV-associated HCC. We find beta catenin to be the most frequently mutated oncogene (15.9%) and TP53 the most frequently mutated tumor suppressor (35.2%). The Wnt/beta catenin and JAK/STAT pathways, altered in 62.5% and 45.5% of cases respectively, are likely to act as two major oncogenic drivers in HCC. This study also identifies several prevalent and potentially actionable mutations including activating mutations of Janus Kinase 1 (JAK1) in 9.1% of patients and provides a path towards therapeutic intervention of the disease.</p>
<a href='http://genome.cshlp.org/content/early/2013/06/19/gr.154492.113'>read more</a>
    </div>

    

  
    <ul class="tag_box inline">
      <li><i class="icon-tags"></i></li>
      
      


  
     
    	<li><a href="/tags.html#LiLin-ref">LiLin <span>6</span></a></li>
    
  



    </ul>
    

    <hr>
    <div class="pagination">
      <ul>
      
        <li class="prev disabled"><a>&larr; Previous</a></li>
      
        <li><a href="/archive.html">Archive</a></li>
      
        <li class="next"><a href="/2013/10/13/Whole-genome-and-whole-exome-sequencing-of-bladder-cancer-identifies-frequent-alterations-in-genes-involved-in-sister-chromatid-cohesion-and-segregation" title="Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation">Next &rarr;</a></li>
      
      </ul>
    </div>
    <hr>
    
  </div>
</div>


      </div>
      <hr>
      <footer>
        <p align="center">&copy; 2014 BGICR</p>
      </footer>

    </div>

    
  </body>
</html>

